戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ay play a role in neoangiogenesis (postnatal vasculogenesis).
2 ar homeostasis by participating in postnatal vasculogenesis.
3 h as synaptogenesis, boundary formation, and vasculogenesis.
4 he coronary vasculature during early cardiac vasculogenesis.
5 actors (HIFs) and the patterning of coronary vasculogenesis.
6  CD31, indicating potential roles of MLL1 in vasculogenesis.
7 cule 1 (PECAM), and aquaporin 1, a marker of vasculogenesis.
8 on to enable persistent cell motility and 3D vasculogenesis.
9 es, thereby increasing both angiogenesis and vasculogenesis.
10  to study VEGFR-1 activation in pathological vasculogenesis.
11 GF-1R(+) hCSCs improved cardiomyogenesis and vasculogenesis.
12 and pathologic processes involving postnatal vasculogenesis.
13 ucial downstream pathway leading to aberrant vasculogenesis.
14  in vitro before implantation also inhibited vasculogenesis.
15 s, which themselves form by the mechanism of vasculogenesis.
16 vel therapeutic target for the inhibition of vasculogenesis.
17 xial vessels during angioblast migration and vasculogenesis.
18 ateral plate mesoderm by Hh signaling during vasculogenesis.
19 tional blood vessels during angiogenesis and vasculogenesis.
20 "angioblast" progenitors in a process called vasculogenesis.
21  play a critical role in postnatal and tumor vasculogenesis.
22  effects contributed to cardiomyogenesis and vasculogenesis.
23 lls (ECs) and smooth muscle cells (SMCs) and vasculogenesis.
24 rting their role in directional induction of vasculogenesis.
25 urvival signaling via the promotion of tumor vasculogenesis.
26 ascularization, and in vivo studies of human vasculogenesis.
27 nsights into the role of NRP-1 in a model of vasculogenesis.
28 ys that may mediate glycocalyx regulation of vasculogenesis.
29 t affect MM cell migration, organization, or vasculogenesis.
30 rowth factor (VEGF), which in turn regulates vasculogenesis.
31 d3(-/-) mice, a model of bone marrow-derived vasculogenesis.
32  confirmed a deficit in bone marrow-mediated vasculogenesis.
33 ord blood-derived EPCs in a model of in vivo vasculogenesis.
34 transplantation experiments to examine human vasculogenesis.
35  to demonstrate a crucial role for Zimp10 in vasculogenesis.
36 othelial cells and is critical for embryonic vasculogenesis.
37  10, although there were no overt effects on vasculogenesis.
38 ovascularization, a process termed postnatal vasculogenesis.
39 epresents a critical force that drives adult vasculogenesis.
40 , expression in nonvasculogenic cells caused vasculogenesis.
41 ed that tumor cell-secreted factors regulate vasculogenesis.
42 lial lineages, rescues hematopoiesis but not vasculogenesis.
43 f circulating stem cells is a key feature of vasculogenesis.
44 the setting of compromised host angiogenesis/vasculogenesis.
45 r normalize vasculature rather than initiate vasculogenesis.
46 cardially derived and essential for coronary vasculogenesis.
47 ration, extracellular matrix remodeling, and vasculogenesis.
48 the growth of blood vessels during postnatal vasculogenesis.
49 early embryonic development including normal vasculogenesis.
50 n revealed a requirement for YAP in yolk sac vasculogenesis.
51 ate PDGF-BB as a primary effector of MM cell vasculogenesis.
52 poiesis, but not primitive erythropoiesis or vasculogenesis.
53 e developmental regulation of hemostasis and vasculogenesis.
54 d in neural crest cell (NCC) development and vasculogenesis.
55 present study evaluates the role of KCNH2 in vasculogenesis.
56 evolutionarily conserved master regulator of vasculogenesis.
57 ions results in defects in cardiogenesis and vasculogenesis.
58 t E11.5-12.5 days with associated defects in vasculogenesis.
59 auses embryonic lethality at E15.5 with poor vasculogenesis.
60 processes: angiogenesis, arteriogenesis, and vasculogenesis.
61 angioblastomas are a result of tumor-derived vasculogenesis.
62 onstrated downregulation of genes related to vasculogenesis.
63 ed by NO deficiency may trigger MSC-mediated vasculogenesis.
64 , TGF-beta1-associated fibrosis and impaired vasculogenesis.
65 g both fetoplacental vascular resistance and vasculogenesis.
66 novo from the mesoderm in a process known as vasculogenesis.
67 ory role of S-nitrosylation signaling in MSC vasculogenesis.
68 mportant function in tissue regeneration and vasculogenesis after injury.
69 tion; and vasoformative responses, including vasculogenesis, alternative angiogenic pathways, and vas
70 functions for plexinD1 in post-natal retinal vasculogenesis and adult angiogenesis through the use of
71                                 Importantly, vasculogenesis and angioblast differentiation steps were
72 ing embryogenesis, flk1 is required for both vasculogenesis and angiogenesis and abnormally elevated
73 Cdc42 in ECs caused embryonic lethality with vasculogenesis and angiogenesis defects.
74 EGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and p
75 helial cell motility has fundamental role in vasculogenesis and angiogenesis during developmental or
76 thelial growth factor (VEGF) is required for vasculogenesis and angiogenesis during embryonic and ear
77 )-2C is thought to play an important role in vasculogenesis and angiogenesis during vascular developm
78       The requirement for Notch signaling in vasculogenesis and angiogenesis is well documented.
79 sue of the JCI, Kioi et al. demonstrate that vasculogenesis and angiogenesis potentially play distinc
80 perinatal vascular development revealed that vasculogenesis and angiogenesis proceed normally in thes
81 ntegrins in their endothelial cells, initial vasculogenesis and angiogenesis proceed normally, at lea
82 lex and requires a number of steps including vasculogenesis and angiogenesis that are followed by dif
83 dothelial lineage and neovascular processes (vasculogenesis and angiogenesis) we evaluated endothelia
84 ic mouse has been an excellent tool to study vasculogenesis and angiogenesis, a lymphatic-specific fl
85 re required in endothelial cells for initial vasculogenesis and angiogenesis, although they are requi
86  vasculature forms via the dual processes of vasculogenesis and angiogenesis, and is regulated at mul
87 and AcSDKP as potent stimulators of coronary vasculogenesis and angiogenesis, and reveals Tbeta4-indu
88  is thought to originate by a combination of vasculogenesis and angiogenesis, but how these processes
89 rowth factor (VEGF)-A has essential roles in vasculogenesis and angiogenesis, but the downstream step
90                                       During vasculogenesis and angiogenesis, endothelial cell respon
91 se findings demonstrate that Kmt2d regulates vasculogenesis and angiogenesis, provide evidence for in
92 ell specification and differentiation during vasculogenesis and angiogenesis.
93  been shown to be important during embryonic vasculogenesis and angiogenesis.
94 gulates EC proliferation and adhesion during vasculogenesis and angiogenesis.
95 y may be attributable to defects in yolk sac vasculogenesis and angiogenesis.
96 ive hematopoiesis and the inhibition of both vasculogenesis and angiogenesis.
97 wth factor-A (VEGF-A) signaling directs both vasculogenesis and angiogenesis.
98 ve model for the study of human disorders of vasculogenesis and angiogenesis.
99 odulate phosphotyrosine signaling to promote vasculogenesis and angiogenesis.
100 lective behavior of endothelial cells during vasculogenesis and angiogenesis.
101                                   Attenuated vasculogenesis and cardiogenesis during recovery were ev
102 ants revealed important functions of PTIP in vasculogenesis and chorioplacental development that appe
103 al lineage leading to both HSC emergence and vasculogenesis and determine that a single miRNA, miR-14
104 tivation of Tbeta4 is essential for yolk sac vasculogenesis and embryonic survival, and administratio
105  known as a cytokine essential for embryonic vasculogenesis and for the angiogenesis associated with
106 iRNA in a human embryonic stem cell model of vasculogenesis and found that miR-132 was highly express
107 cating a highly conserved role in vertebrate vasculogenesis and haematopoiesis.
108                           PURPOSE OF REVIEW: Vasculogenesis and hematopoiesis are essential for devel
109 actor Etsrp/Etv2/ER71 has been implicated in vasculogenesis and hematopoiesis in multiple vertebrates
110 t via hemovasculogenesis, a process in which vasculogenesis and hematopoiesis occur simultaneously.
111  cofactors will lead to greater insight into vasculogenesis and hematopoiesis, and may help to identi
112 been identified as an essential regulator of vasculogenesis and hematopoiesis.
113 y reported Etv2 as an essential regulator of vasculogenesis and hematopoiesis.
114 at moderate doses, ethanol directly promotes vasculogenesis and improves microvascular function, resu
115 tment and endothelial cell activation during vasculogenesis and ischemia-mediated arteriogenesis coul
116  Our results suggest a role for adenosine in vasculogenesis and its potential use to stimulate engraf
117 trophils recently identified as mediators of vasculogenesis and metastasis, were recruited to the tum
118  Ly6G antibodies prevented ELF5 from driving vasculogenesis and metastasis.
119 es have implicated hypoxia in the control of vasculogenesis and permeability, the basis for which is
120 le roles for MT1-MMP or MT2-MMP in placental vasculogenesis and provide the first example of selectiv
121 storing the radiation-damaged vasculature by vasculogenesis and thereby allowing the growth of surviv
122 nstrates that Sag is essential for embryonic vasculogenesis and tumor angiogenesis, and provides the
123 t MLL1 is a key factor in hypoxia signaling, vasculogenesis and tumor growth, and its depletion suppr
124 pulation that appears to participate in both vasculogenesis and vascular homeostasis.
125 in essential processes such as angiogenesis, vasculogenesis and vascular permeability.
126 ole for Cx43alpha1 gap junctions in coronary vasculogenesis and vascular remodeling.
127 ial progenitor cells (EPCs) are essential in vasculogenesis and wound healing, but their circulating
128 or the differentiation of endothelial cells (vasculogenesis) and for the sprouting of new capillaries
129 s regulating de novo blood vessel formation (vasculogenesis) and remodeling (angiogenesis) come from
130 ion of vessels from endothelial progenitors (vasculogenesis) and sprouting of vessels from pre-existi
131 rnal spiral arterioles, dysregulated villous vasculogenesis, and abundant fibrin deposition are chara
132 ll junctions regulate vascular permeability, vasculogenesis, and angiogenesis.
133 mental processes such as boundary formation, vasculogenesis, and cell migration.
134             Fluid flow is also important for vasculogenesis, and evidence suggests that fluid shear s
135  tumor metrics are quantified (e.g., growth, vasculogenesis, and metastasis).
136 ng difficulties, abnormal peripheral retinal vasculogenesis, and rod-cone dystrophy were investigated
137 low in the main trunk vessels, which form by vasculogenesis, and the intersomitic vessels, which form
138 leading to major insights into angiogenesis, vasculogenesis, and tumor biology.
139  genes involved in embryonic development and vasculogenesis, and up-regulation of genes involved in h
140 nteraction between SEMA3A and VEGF164 during vasculogenesis, angiogenesis or limb axon patterning, su
141                                              Vasculogenesis, angiogenesis, and maturation are three m
142 ctors with roles in development that include vasculogenesis, angiogenesis, haematopoiesis and bone de
143 ized by high expression of genes involved in vasculogenesis, angiogenesis, tumorigenesis and associat
144 d determining the effects of the knockout on vasculogenesis, angiogenic remodeling, and the regulatio
145                        Both angiogenesis and vasculogenesis are disrupted in the hyperoxia-induced va
146 target of Hand1 and reveal impaired yolk sac vasculogenesis as a primary cause of early embryonic let
147  Formation of embryonic vasculature involves vasculogenesis as endothelial cells differentiate and ag
148                                  The role of vasculogenesis as opposed to angiogenesis in tumor forma
149 ed by fibrobalst growth factor receptor 1 in vasculogenesis as vascular endothelial growth factor sup
150                Recent evidence suggests that vasculogenesis as well as angiogenesis occurs throughout
151 ctors, and, in part, directly contributed to vasculogenesis, as demonstrated by both 3D confocal micr
152 of the identified proteins was assessed in a vasculogenesis assay in vivo by using a morpholino strat
153 an umbilical vein endothelial cells and in a vasculogenesis assay in which differentiated embryonic s
154               This caused defective coronary vasculogenesis associated with impaired vascular smooth
155 work formation is enriched for migration and vasculogenesis-associated genes that predict survival in
156  Taken together, CUL2 is required for normal vasculogenesis, at least in part mediated by its regulat
157 growth factor (VEGF) plays a crucial role in vasculogenesis (blood vessel formation) and angiogenesis
158  (RTK) signaling and play important roles in vasculogenesis, bone morphogenesis, and renal uteric bra
159  cardiac looping and have defective yolk sac vasculogenesis, both cardiac and yolk sac morphology of
160  in common for developmental cell migration, vasculogenesis, branching morphogenesis, as well as neur
161 primary vascular plexus indicative of intact vasculogenesis but failed to induce the secondary vascul
162  UBR4-deficient YS normally advances through vasculogenesis but is arrested during angiogenic remodel
163 spo1 receptor kremen form primary vessels by vasculogenesis, but are defective in subsequent angiogen
164 y participate in the modulation of postnatal vasculogenesis by inhibiting EPC differentiation.
165  neovascular microenvironment may facilitate vasculogenesis by promoting endothelial differentiation
166 udy elucidates the potential coregulation of vasculogenesis by the heparan sulfate glycosaminoglycan-
167 es of matrix biomechanics on early stages of vasculogenesis by using hydrogels with tunable stiffness
168                                              Vasculogenesis can be mimicked and studied in vitro usin
169 hese studies indicate that tubulogenesis and vasculogenesis can be partially recapitulated by recombi
170                             During embryonic vasculogenesis, CD24 expression is down-regulated in hum
171 P in the developmental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryoni
172 electively targeted endothelium generated by vasculogenesis, completely inhibiting vessel formation m
173 as emerged as an advantageous model to study vasculogenesis, cranial vasculature is thought to origin
174 c phenotype consists of a previously unknown vasculogenesis defect that affects endocardium patternin
175 k-in of the TGF-beta3 ligand can prevent the vasculogenesis defects and autoimmunity associated with
176 splay the major features of Tgfb1(-/-) mice (vasculogenesis defects, multiorgan inflammation, and lac
177 nto the germ line of mice (ILK-VT/GG) caused vasculogenesis defects, resulting in a general developme
178                                 We show that vasculogenesis-driven and angiogenesis-driven tumors gro
179 ator of endothelial cell differentiation and vasculogenesis during both development and tumor vascula
180 ransforming growth factor beta activation in vasculogenesis during development, immune regulation, an
181 protein required for proper angiogenesis and vasculogenesis during development.
182 nown for its involvement in angiogenesis and vasculogenesis during ontogeny.
183         Differing from both angiogenesis and vasculogenesis, during canalogenesis SECs express Prox1,
184 Unlike angiogenesis and similar to stages of vasculogenesis, during canalogenesis tip cells divide an
185 n solid tumors, hypoxia triggers an aberrant vasculogenesis, enhances malignant character, and elevat
186 by hemo-vasculogenesis, the process by which vasculogenesis, erythropoiesis, and hematopoiesis occur
187 otein (BMP) antagonist capable of inhibiting vasculogenesis even in the presence of provasculogenic V
188 igration, controlled cellular proliferation, vasculogenesis, extracellular matrix and hormone secreti
189 ve extraembryonic mesoderm morphogenesis and vasculogenesis, failure to close the ectoplacental cavit
190  and pathophysiological processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumou
191  erythroid cells, and an absence of yolk sac vasculogenesis, followed by embryonic lethality at embry
192 , vascular progenitor cell-driven 'postnatal vasculogenesis' has been suggested as an important mecha
193  target), zCul2 morpholino blocked embryonic vasculogenesis in a manner similar to that caused by inh
194 , a VEGFR1-specific agonist, increased tumor vasculogenesis in a murine BMT model.
195 s exhibited markedly diminished capacity for vasculogenesis in an in vitro Matrigel tube-forming assa
196          Whether Sag is required for de novo vasculogenesis in embryos and angiogenesis in tumors is
197 nesis and cardiac development, have aberrant vasculogenesis in embryos, yolk sacs and placentas, and
198                 These findings indicate that vasculogenesis in endometriotic lesions is dependent on
199 rate that the inhibition of COX-2 suppresses vasculogenesis in endometriotic lesions, which may contr
200 ses of vascular co-option, angiogenesis, and vasculogenesis in gliomas have been extensively describe
201                     Our results suggest that vasculogenesis in human MM may develop from tumoral prod
202 at mutant ZNF408 results in abnormal retinal vasculogenesis in humans and is associated with FEVR.
203 nd thereby promote cellular interactions and vasculogenesis in IH.
204  differentiation that underpins pathological vasculogenesis in IH.
205 ulated MM cell proliferation, migration, and vasculogenesis in monolayer and organization of the cell
206 utics to normalize impaired ischemia-induced vasculogenesis in patients with diabetes.
207  for this compound in ECs) strongly disrupts vasculogenesis in pluripotent embryonic stem cell cultur
208 r example, it has been shown that inadequate vasculogenesis in systemic sclerosis (SSc) has been asso
209               We found that VJ115 suppressed vasculogenesis in Tg(fli1-eGFP) embryos and impaired cir
210                        A role for PDGF-BB in vasculogenesis in the 3D MM/UB co-culture system was val
211      Surprisingly, c-myc is not required for vasculogenesis in the embryo.
212 XBP1 (XBP1ecko) in mice retarded the retinal vasculogenesis in the first 2 postnatal weeks and impair
213 the Mekk3 gene to evaluate the importance of vasculogenesis in the formation of Ewing's sarcoma tumor
214 ne led to dose-dependent inhibition of tumor vasculogenesis in the murine model.
215                     These included defective vasculogenesis in the placental labyrinth, a collapsed e
216 asculature are distinct from those governing vasculogenesis in the rest of the embryo.
217 as both necessary and sufficient to initiate vasculogenesis in the zebrafish embryos.
218 this link, we analyzed OF fusion and hyaloid vasculogenesis in the zebrafish pax2a noi mutant line.
219               There was a marked increase in vasculogenesis in vitro as measured by angiogenesis assa
220 deal platform for the investigation of renal vasculogenesis in vitro.
221 n of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues t
222  pericyte/vSMC formation in vitro and during vasculogenesis in vivo using 2 Ewing sarcoma mouse model
223 F-A in hemangioma-derived stem cells reduced vasculogenesis in vivo.
224 f VEGF-A expression in these cells inhibited vasculogenesis in vivo.
225  levels at the site of tumor growth promoted vasculogenesis in vivo.
226   These findings support animal studies that vasculogenesis, in addition to angiogenesis, may contrib
227 v2 activates expression of genes involved in vasculogenesis, including Fli1.
228 disrupt specific stages of hematopoiesis and vasculogenesis, including the cloche, spadetail (tbx16),
229 ng surfactant lipid and protein homeostasis, vasculogenesis, including Vegfa, and smooth muscle cell
230 nce of endothelial progenitor cells in adult vasculogenesis increased further, the role of these como
231 many of the defects responsible for impaired vasculogenesis involve HIF1-regulated genes, we hypothes
232 ericyte recruitment to EC-lined tubes during vasculogenesis is a stimulatory event controlling vascul
233                                  Therapeutic vasculogenesis is an emerging concept that can potential
234                   Our findings indicate that vasculogenesis is critical in the expansion of the tumor
235                    An unresolved question in vasculogenesis is how mammalian endothelial cells make l
236  angiogenesis is normal in the model whereas vasculogenesis is impaired.
237 helial cells initiate lumen formation during vasculogenesis is not known.
238 ted to mammals a normal component of primary vasculogenesis is production of endothelial cells that e
239                   Furthermore, we found that vasculogenesis is significant for tumors because it gene
240                                     Coronary vasculogenesis is significantly impaired in null mice, w
241 ole of bone morphogenetic proteins (BMPs) in vasculogenesis is still not well understood, despite man
242                                              Vasculogenesis is the de novo formation of a vascular ne
243  new blood vessels from preexisting vessels; vasculogenesis is the formation of new vessels by recrui
244 lar cell types; this suggests that defective vasculogenesis may disrupt cerebellar development.
245 y genes associated with learning and memory, vasculogenesis, neurogenesis, cell survival pathways, Ab
246 atopoiesis (no effect on gata1 or h-bae1) or vasculogenesis (no effect on kdrl, ephb2a, notch3, dab2,
247                                              Vasculogenesis occurs normally in mice lacking VE-PTP; h
248 erentiation of mesenchymal cells and reduced vasculogenesis of the splenic primordium.
249                                       Severe vasculogenesis or angiogenesis defects in embryos are in
250  genes and involvement of pathways common to vasculogenesis or angiogenesis in other parts of the emb
251 on pathways that are known to be involved in vasculogenesis or angiogenesis, were found to have expre
252 e formation using in vitro assays that mimic vasculogenesis or angiogenic sprouting in 3D collagen ma
253 f existing NV, without appreciably affecting vasculogenesis or retinal revascularization.
254                  Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from pr
255 d cells affect cardiac development, yolk sac vasculogenesis, or viability in the mouse.
256 Combined SDF-1 and VEGF expression augmented vasculogenesis over SDF-1 expression alone.
257 ent of GBM: in addition to radiotherapy, the vasculogenesis pathway needs to be blocked, and this can
258 rvations indicate that dysregulated coronary vasculogenesis plays a pivotal role in formation of the
259  activated in endothelial progenitors during vasculogenesis prior to blood vessel morphogenesis and i
260   In Etsrp knockdown embryos initial cranial vasculogenesis proceeds normally but endothelial and mye
261 airs surrogate markers of tumor angiogenesis/vasculogenesis, providing support for the concept that E
262 malizing the expression of angiogenesis- and vasculogenesis-related molecules and endothelial Fli1, w
263 s been well characterized, its role in adult vasculogenesis remains poorly understood.
264 , and the role of Tbx5 in mammalian coronary vasculogenesis, remains largely unknown.
265 lysis at 3 developmental stages critical for vasculogenesis revealed a cascade of pathways that may m
266 een the glycome and the transcriptome during vasculogenesis, revealing the possibility of harnessing
267 interrogation reveals an atypical VEGF-based vasculogenesis signalling that facilitates recruitment o
268  (VCAM-1) were performed in murine models of vasculogenesis (subcutaneous matrigel) or hind-limb isch
269 nuum mathematical models to explore in vitro vasculogenesis: such models describe cell ensembles but
270 he yolk sac and dorsal aorta, that undergoes vasculogenesis, the de novo formation of blood vessels.
271                  Mechanisms underlying tumor vasculogenesis, the homing and engraftment of bone marro
272  like the choriocapillaris, develops by hemo-vasculogenesis, the process by which vasculogenesis, ery
273 and heterotypic signals that enhance TAM and vasculogenesis, these processes may contribute to NF-kap
274                     Tissue ischemia promotes vasculogenesis through chemokine-induced recruitment of
275                              CLIC4 regulates vasculogenesis through endothelial tube formation.
276 to 24 h genes known to regulate angiogenesis/vasculogenesis to identify pathways programming deviant
277 e a novel multicellular agent-based model of vasculogenesis using the CompuCell3D modeling environmen
278  the potential of two principal effectors of vasculogenesis, vascular endothelial growth factor A (VE
279 described: vascular co-option, angiogenesis, vasculogenesis, vascular mimicry, and (the most recently
280 Nonetheless, recent studies demonstrate that vasculogenesis, vascular remodeling, and angiogenesis ar
281 st local VEGF and/or PlGF expression promote vasculogenesis; VEGF plays a role in EPC recruitment and
282 ting that GATA transcription factors promote vasculogenesis via activation of downstream targets, whi
283                     Histological analysis of vasculogenesis was performed with platelet endothelial c
284 nduced arteriogenesis, whereas developmental vasculogenesis was unaffected.
285 olecules associated with angiogenesis and/or vasculogenesis) was reversed along with the reversal of
286  whether Myc indeed contributes to embryonic vasculogenesis we evaluated Myc function in Xenopus laev
287 fragility and subsequent defects in yolk sac vasculogenesis, we expressed Tmod1 specifically in the m
288 een the glycome and the transcriptome during vasculogenesis, we identified by microarray and then val
289  To explore a potential role of Flk-1 in the vasculogenesis, we investigated two glioblastoma cell li
290          Using a 3D in vitro tissue model of vasculogenesis, we observed increased vascularization in
291  placental labyrinth, basement membranes and vasculogenesis were normal in embryo and yolk sac.
292 erentiation of endothelial cells is known as vasculogenesis, whereas the growth of new blood vessels
293  exhibit severe defects in hematopoiesis and vasculogenesis, whereas the single knockouts do not.
294 l with the capacity for cardiomyogenesis and vasculogenesis which contribute, at least in part, to th
295 on depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization o
296 reduction in proliferation and impairment of vasculogenesis, which were associated with induction of
297 als that NHFs enhance blastema formation and vasculogenesis, while MWFs inhibit fibrogenesis and indu
298 suggested that these blood vessels formed by vasculogenesis, while the current concept seems to favor
299 lular proliferation in the midface, aberrant vasculogenesis with decreased productive vessel branchin
300 eby provide a novel mechanism for regulating vasculogenesis, with direct relevance to physiological a
301 tinct cytokine binding domains, has roles in vasculogenesis, wound healing responses, and fibrogenesi

 
Page Top